VN1R84P

Across TCGA pan-cancer cohorts, VN1R84P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of VN1R84P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where VN1R84P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types VN1R84P is over-expressed in tumor.

BRCA, BLCA, and LIHC are the cancer types where VN1R84P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in VN1R84P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	+0.289	.010	4	view →
BLCA	All	IV	+0.587	.033	2	view →
LIHC	All	All	+0.161	.001	2	view →
STAD	Male	All	+0.472	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

VN1R84P–BRCA

Open the BRCA breakdown →